Re: Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: Results from a phase 3, double-blind, randomised trial

Samir S. Taneja

doi:10.1016/j.juro.2014.12.077

Re: Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: Results from a phase 3, double-blind, randomised trial

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	847-848
Number of pages	2
Journal	Journal of Urology
Volume	193
Issue number	3
DOIs	https://doi.org/10.1016/j.juro.2014.12.077
State	Published - Mar 1 2015

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2014.12.077

Cite this

@article{ed5054a5ac1d48eab7e4b99e70cfa54e,

title = "Re: Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: Results from a phase 3, double-blind, randomised trial",

author = "Taneja, {Samir S.}",

year = "2015",

month = mar,

day = "1",

doi = "10.1016/j.juro.2014.12.077",

language = "English (US)",

volume = "193",

pages = "847--848",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Re

T2 - Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: Results from a phase 3, double-blind, randomised trial

AU - Taneja, Samir S.

PY - 2015/3/1

Y1 - 2015/3/1

UR - http://www.scopus.com/inward/record.url?scp=84922567209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922567209&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2014.12.077

DO - 10.1016/j.juro.2014.12.077

M3 - Comment/debate

C2 - 25765385

AN - SCOPUS:84922567209

SN - 0022-5347

VL - 193

SP - 847

EP - 848

JO - Journal of Urology

JF - Journal of Urology

IS - 3

ER -

Re: Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: Results from a phase 3, double-blind, randomised trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this